S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20
S&P 500   4,591.67
DOW   35,227.03
QQQ   386.20

Compare Stocks

Date Range: 

 Codex DNAHarvard BioscienceEyePoint PharmaceuticalsAccelerate DiagnosticsFluidigm
SymbolNASDAQ:DNAYNASDAQ:HBIONASDAQ:EYPTNASDAQ:AXDXNASDAQ:FLDM
Price Information
Current Price$6.41$6.64$14.54$4.77$4.25
50-Day Moving Average$9.45$7.25$13.22$5.83$5.11
52-Week Low$6.22$3.83$4.00$4.71$3.71
52-Week High$25.70$8.75$21.50$15.60$7.51
MarketRank™
Overall Score1.82.42.32.72.0
Analysis Score3.53.53.53.53.5
Community Score4.74.94.84.55.0
Dividend Score0.00.00.00.00.0
Ownership Score0.81.73.35.01.7
Earnings & Valuation Score0.01.90.00.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$23.19$9.00$22.38$9.00$7.00
% Upside from Price Target261.78% upside35.54% upside53.89% upside88.68% upside64.71% upside
Trade Information
Market Cap$187.86 million$270.99 million$492.82 million$293.35 million$325.07 million
BetaN/A1.771.131.791.22
Average Volume116,844208,245374,490349,2231,373,403
Sales & Book Value
Annual RevenueN/A$102.10 million$34.44 million$11.16 million$138.14 million
Price / SalesN/A2.6514.3126.292.35
CashflowN/A$0.31 per shareN/AN/AN/A
Price / CashN/A21.73N/AN/AN/A
Book Value$3.51 per share$1.88 per share$2.74 per share($0.65) per share$1.30 per share
Price / BookN/A3.535.31-7.343.27
Profitability
Net IncomeN/A$-7.81 million$-45.39 million$-78.21 million$-53.02 million
EPSN/A($0.05)($2.50)($1.25)($0.90)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/A22.13N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-1.60%-167.42%-639.62%-49.54%
Return on Equity (ROE)N/A9.59%-64.16%N/A-43.70%
Return on Assets (ROA)N/A4.82%-34.22%-81.72%-17.12%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.130.560.39N/A0.64
Current Ratio14.932.377.119.521.55
Quick Ratio14.721.266.888.231.04
Ownership Information
Institutional Ownership Percentage55.18%68.92%74.10%67.27%75.63%
Insider Ownership PercentageN/A5.40%26.74%45.30%2.90%
Miscellaneous
Employees101444100224627
Shares Outstanding29.31 million40.81 million33.89 million61.50 million76.49 million
Next Earnings Date2/8/2022 (Estimated)3/9/2022 (Estimated)3/3/2022 (Estimated)2/22/2022 (Estimated)2/9/2022 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable
SourceHeadline
Analysts Provide Insight On How High Fluidigm Corporation (FLDM) Can GoAnalysts Provide Insight On How High Fluidigm Corporation (FLDM) Can Go
stocksregister.com - December 4 at 9:05 AM
RT-PCR Test Market is Booming Worldwide with Bioer, Abbott Laboratories, Biosynex, Thermo Fisher Scientific – UK Parents Lounge - UK Parents LoungeRT-PCR Test Market is Booming Worldwide with Bioer, Abbott Laboratories, Biosynex, Thermo Fisher Scientific – UK Parents Lounge - UK Parents Lounge
ukparentslounge.com - December 3 at 2:27 PM
Fluidigm (NASDAQ:FLDM) vs. Olink Holding AB (publ) (NASDAQ:OLK) Critical SurveyFluidigm (NASDAQ:FLDM) vs. Olink Holding AB (publ) (NASDAQ:OLK) Critical Survey
americanbankingnews.com - November 29 at 3:14 PM
Global Microfluidics Market Trends and Forecasts to 2026: Shifting Trend Towards E-Health Diagnostics With the Integration of Microfluidics-Based POC - ACROFAN USAGlobal Microfluidics Market Trends and Forecasts to 2026: Shifting Trend Towards E-Health Diagnostics With the Integration of Microfluidics-Based POC - ACROFAN USA
us.acrofan.com - November 26 at 1:17 PM
Chip-based Digital PCR Systems Market analysis with Leading Key Players and Regional Analysis 2026 - Northwest Diamond NotesChip-based Digital PCR Systems Market analysis with Leading Key Players and Regional Analysis 2026 - Northwest Diamond Notes
nwdiamondnotes.com - November 26 at 8:16 AM
Global Microfluidics Market Trends and Forecasts to 2026: Shifting Trend Towards E-Health Diagnostics With the Integration of Microfluidics-Based POC Devices, Epidermal Electronics and IoT - ResearchAndMarkets.com - Business WireGlobal Microfluidics Market Trends and Forecasts to 2026: Shifting Trend Towards E-Health Diagnostics With the Integration of Microfluidics-Based POC Devices, Epidermal Electronics and IoT - ResearchAndMarkets.com - Business Wire
businesswire.com - November 26 at 8:16 AM
RT-PCR Kits Market 2020 (COVID-19 Impact Analysis Included) Opportunities, Regional Overview, Top Le - PharmiWeb.comRT-PCR Kits Market 2020 (COVID-19 Impact Analysis Included) Opportunities, Regional Overview, Top Le - PharmiWeb.com
pharmiweb.com - November 25 at 9:38 AM
10x Genomics Stock: Bull vs. Bear - Motley Fool10x Genomics Stock: Bull vs. Bear - Motley Fool
fool.com - November 24 at 12:51 PM
Worldwide Single Cell Genomics Industry Report to 2026 - Technology Maturity & Convergence are Driving Growth - WFMZ AllentownWorldwide Single Cell Genomics Industry Report to 2026 - Technology Maturity & Convergence are Driving Growth - WFMZ Allentown
wfmz.com - November 24 at 7:36 AM
Multi-PCR Detection Market is Anticipated to Witness Outstanding Growth Over the forecast period 2021-2027 Alo - openPRMulti-PCR Detection Market is Anticipated to Witness Outstanding Growth Over the forecast period 2021-2027 Alo - openPR
openpr.com - November 23 at 12:56 PM
Insights on the Single Cell Genomics Global Market to 2026 - GlobeNewswireInsights on the Single Cell Genomics Global Market to 2026 - GlobeNewswire
globenewswire.com - November 23 at 12:56 PM
Global Microfluidic Chips Market 2021-2027 Regional Analysis, Types, and Applications - Top Key Players as Agilent, Fluidigm Corporation, Micralyne, Inc - Big News NetworkGlobal Microfluidic Chips Market 2021-2027 Regional Analysis, Types, and Applications - Top Key Players as Agilent, Fluidigm Corporation, Micralyne, Inc - Big News Network
bignewsnetwork.com - November 23 at 7:55 AM
Worldwide Sequencing Reagents Industry to 2028 - Focus on Oncology, Clinical Investigation, Agri Genomics & Forensics and Reproductive Health - Yahoo FinanceWorldwide Sequencing Reagents Industry to 2028 - Focus on Oncology, Clinical Investigation, Agri Genomics & Forensics and Reproductive Health - Yahoo Finance
finance.yahoo.com - November 22 at 7:59 AM
Fluidigm Corporation’s (FLDM) Outlook: Recollecting The Past For Future InsightsFluidigm Corporation’s (FLDM) Outlook: Recollecting The Past For Future Insights
stocksregister.com - November 22 at 1:00 AM
People in the News: New Appointments at Rebus Biosystems, Jumpcode Genomics, Epigenomics, More - GenomeWebPeople in the News: New Appointments at Rebus Biosystems, Jumpcode Genomics, Epigenomics, More - GenomeWeb
genomeweb.com - November 19 at 3:00 PM
Insights on the Sequencing Reagents Global Market to 2028 - Funding by Manufacturers and Government in Genomics Presents Opportunities - Yahoo FinanceInsights on the Sequencing Reagents Global Market to 2028 - Funding by Manufacturers and Government in Genomics Presents Opportunities - Yahoo Finance
finance.yahoo.com - November 19 at 9:30 AM
Worldwide Polymerase Chain Reaction Industry to 2026 - Featuring BioMerieux, Fluidigm and Promega Among Others - PRNewswireWorldwide Polymerase Chain Reaction Industry to 2026 - Featuring BioMerieux, Fluidigm and Promega Among Others - PRNewswire
prnewswire.com - November 19 at 9:30 AM
Worldwide Polymerase Chain Reaction Industry to 2026 - Featuring BioMerieux, Fluidigm and Promega Among Others - Yahoo FinanceWorldwide Polymerase Chain Reaction Industry to 2026 - Featuring BioMerieux, Fluidigm and Promega Among Others - Yahoo Finance
finance.yahoo.com - November 18 at 9:16 AM
Single Cell Analysis Market to Exhibit Positive and Steady Growth, Players – Agilent Technologies, Fluidigm Corporation. – Energy Siren - Energy SirenSingle Cell Analysis Market to Exhibit Positive and Steady Growth, Players – Agilent Technologies, Fluidigm Corporation. – Energy Siren - Energy Siren
energysiren.co.ke - November 17 at 9:03 AM
Single-Cell Analysis Market Size, Growth (2021-2028) | Top Companies – Merck, Thermo Fisher Scientific, Becton Dickinson, Beckman Coulter, Bio-Rad Laboratories, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Fluidigm Corporation, – Energy Sire - Energy SirenSingle-Cell Analysis Market Size, Growth (2021-2028) | Top Companies – Merck, Thermo Fisher Scientific, Becton Dickinson, Beckman Coulter, Bio-Rad Laboratories, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Fluidigm Corporation, – Energy Sire - Energy Siren
energysiren.co.ke - November 17 at 4:02 AM
Sample Preparation Products for Next Generation Sequencing Market: Size, Growth, Forecast, Business Outlook 2021-2027 | 10X Genomics, Pacific Biosciences, Fluidigm, Agilent Technologies, Oxford Nan…. – Energy Siren - Energy SirenSample Preparation Products for Next Generation Sequencing Market: Size, Growth, Forecast, Business Outlook 2021-2027 | 10X Genomics, Pacific Biosciences, Fluidigm, Agilent Technologies, Oxford Nan…. – Energy Siren - Energy Siren
energysiren.co.ke - November 17 at 4:02 AM
Library Preparation and Target Enrichment for Next Generation Sequencing Product Market: Size, Growth, Forecast, Business Outlook 2021-2027 | Fluidigm, Roche, Illumina, Thermo Fisher Scientific, Ag…. – Energy Siren - Energy SirenLibrary Preparation and Target Enrichment for Next Generation Sequencing Product Market: Size, Growth, Forecast, Business Outlook 2021-2027 | Fluidigm, Roche, Illumina, Thermo Fisher Scientific, Ag…. – Energy Siren - Energy Siren
energysiren.co.ke - November 17 at 4:02 AM
Digital PCR-dPCR Market Size, Growth (2021-2028) | Top Companies – Fluidigm, Bio-rad, Thermo Fisher, RainDance Technologies, – Energy Siren - Energy SirenDigital PCR-dPCR Market Size, Growth (2021-2028) | Top Companies – Fluidigm, Bio-rad, Thermo Fisher, RainDance Technologies, – Energy Siren - Energy Siren
energysiren.co.ke - November 17 at 4:02 AM
Polymerase Chain Reaction (PCR) Technologies Market Rugged Expansion Foreseen by 2026 – Fluidigm Corporation, Bio-Rad Laboratories, Inc., Qiagen NV, LGC Limited, etc – Energy Siren - Energy SirenPolymerase Chain Reaction (PCR) Technologies Market Rugged Expansion Foreseen by 2026 – Fluidigm Corporation, Bio-Rad Laboratories, Inc., Qiagen NV, LGC Limited, etc – Energy Siren - Energy Siren
energysiren.co.ke - November 17 at 4:02 AM
MEMS (Biosensors and Nanosensors) Market Size, Growth (2021-2028) | Top Companies – Abbott Laboratories, Agilent Technologies, Bruker Corp., Robert Bosch Gmbh, Thermo Fisher Scientific Inc., Panasonic Corp., Bio-Rad Laboratories, Cepheid Therape - Energy SirenMEMS (Biosensors and Nanosensors) Market Size, Growth (2021-2028) | Top Companies – Abbott Laboratories, Agilent Technologies, Bruker Corp., Robert Bosch Gmbh, Thermo Fisher Scientific Inc., Panasonic Corp., Bio-Rad Laboratories, Cepheid Therape - Energy Siren
energysiren.co.ke - November 16 at 5:16 PM
DateCompanyBrokerageAction
11/15/2021EyePoint PharmaceuticalsCowen
Boost Price Target
11/15/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
10/15/2021Codex DNACowen
Initiated Coverage
10/13/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
7/21/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
7/13/2021Codex DNAJefferies Financial Group
Initiated Coverage
7/13/2021Codex DNACowen
Initiated Coverage
7/13/2021Codex DNAKeyCorp
Initiated Coverage
7/9/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
7/2/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
5/26/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
5/12/2021FluidigmPiper Sandler
Lower Price Target
5/10/2021Accelerate DiagnosticsPiper Sandler
Lower Price Target
5/6/2021EyePoint PharmaceuticalsHC Wainwright
Lower Price Target
3/10/2021Harvard BioscienceKeyCorp
Boost Price Target
3/1/2021EyePoint PharmaceuticalsCowen
Initiated Coverage
2/11/2021FluidigmPiper Sandler
Lower Price Target
1/29/2021EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
1/27/2021EyePoint PharmaceuticalsCantor Fitzgerald
Initiated Coverage
1/12/2021EyePoint PharmaceuticalsB. Riley
Boost Price Target
1/7/2021Harvard BioscienceBenchmark
Upgrade
12/9/2020Harvard BioscienceNorthland Securities
Initiated Coverage
11/9/2020Harvard BioscienceKeyCorp
Initiated Coverage
11/6/2020Accelerate DiagnosticsPiper Sandler
Lower Price Target
10/9/2020EyePoint PharmaceuticalsHC Wainwright
Upgrade
10/7/2020Accelerate DiagnosticsBTIG Research
Initiated Coverage
8/27/2020FluidigmUBS Group
Boost Price Target
8/10/2020Accelerate DiagnosticsPiper Sandler
Boost Price Target
8/10/2020FluidigmUBS Group
Boost Price Target
8/7/2020Accelerate DiagnosticsCraig Hallum
Upgrade
8/7/2020FluidigmPiper Sandler
Boost Price Target
8/6/2020EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
7/9/2020FluidigmPiper Sandler
Reiterated Rating
7/9/2020FluidigmBTIG Research
Reiterated Rating
5/11/2020Accelerate DiagnosticsPiper Sandler
Lower Price Target
4/6/2020EyePoint PharmaceuticalsB. Riley
Downgrade
4/2/2020EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
3/3/2020EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
2/27/2020Harvard BioscienceBenchmark
Boost Price Target
2/11/2020FluidigmPiper Sandler
Lower Price Target
2/4/2020EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
1/24/2020EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
1/14/2020Accelerate DiagnosticsPiper Sandler
Boost Price Target
12/9/2019Harvard BioscienceBenchmark
Downgrade
11/11/2019EyePoint PharmaceuticalsHC Wainwright
Downgrade
11/6/2019FluidigmJanney Montgomery Scott
Downgrade
11/5/2019EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
11/4/2019EyePoint PharmaceuticalsLaidlaw
Initiated Coverage
10/18/2019FluidigmUBS Group
Upgrade
9/27/2019Accelerate DiagnosticsJPMorgan Chase & Co.
Downgrade
9/25/2019EyePoint PharmaceuticalsHC Wainwright
Reiterated Rating
9/24/2019EyePoint PharmaceuticalsB. Riley
Lower Price Target
9/12/2019EyePoint PharmaceuticalsGuggenheim
Initiated Coverage
8/9/2019Accelerate DiagnosticsPiper Jaffray Companies
Lower Price Target
7/19/2019Harvard BioscienceBenchmark
Reiterated Rating
7/8/2019Harvard BioscienceJanney Montgomery Scott
Downgrade
5/12/2019Accelerate DiagnosticsBTIG Research
Reiterated Rating
5/3/2019FluidigmPiper Jaffray Companies
Boost Price Target
3/15/2019FluidigmUBS Group
Initiated Coverage
3/13/2019FluidigmBTIG Research
Initiated Coverage
3/13/2019FluidigmPiper Jaffray Companies
Boost Price Target
2/20/2019Accelerate DiagnosticsPiper Jaffray Companies
Boost Price Target
2/18/2019Harvard BioscienceJanney Montgomery Scott
Reiterated Rating
1/11/2019Accelerate DiagnosticsPiper Jaffray Companies
Lower Price Target
1/3/2019FluidigmJanney Montgomery Scott
Upgrade
(Data available from 12/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.